Business

InnoCore's SynBiosys^TM technology is available for licensing by medical device and pharmaceutical companies seeking an advanced drug delivery system for their NCE or generic drug, either or not in combination with a medical device. InnoCore offers the possibility of exclusive licenses on a product-by-product basis.

Often a development agreement and/or feasibility study is linked to the license agreement. This provide our customers with an additional opportunity to benefit from our development expertise and in depth knowledge of our polymer and drug delivery technologies.

We offer different structures of license- and development agreements, depending on the customer's needs and preferences.  For more information on licensing SynBiosys please contact Alfred van der Meer  (Tel: +31 (0)50 3680772)